Interaction ID
ncRI-40643395
Interaction Molecules
hsa-miR-429 -- EPS8
Interaction Level
RNA-RNA
Interaction Class
binding
Data Source
TargetScan with Ago CLIP data
Tags
Organism
Homo sapiens
Tissue or Cell Type
T-REx-293T
Experiment
AGO CLIP
Description
Conserved miRNAs target sites predicted by TargetScan and miRanda overlap with the AGO CLIP dataset
Alias
-
Class
mRNA
Ensembl id
ENSG00000151491
Description
Signaling adapter that controls various cellular protrusions by regulating actin cytoskeleton dynamics and architecture. Depending on its association with other signal transducers, can regulate different processes. Together with SOS1 and ABI1, forms a trimeric complex that participates in transduction of signals from Ras to Rac by activating the Rac- specific guanine nucleotide exchange factor (GEF) activity. Acts as a direct regulator of actin dynamics by binding actin filaments and has both barbed-end actin filament capping and actin bundling activities depending on the context. Displays barbed-end actin capping activity when associated with ABI1, thereby regulating actin-based motility process: capping activity is auto-inhibited and inhibition is relieved upon ABI1 interaction. Also shows actin bundling activity when associated with BAIAP2, enhancing BAIAP2- dependent membrane extensions and promoting filopodial protrusions. Involved in the regulation of processes such as axonal filopodia growth, stereocilia length, dendritic cell migration and cancer cell migration and invasion. Acts as a regulator of axonal filopodia formation in neurons: in the absence of neurotrophic factors, negatively regulates axonal filopodia formation via actin-capping activity. In contrast, it is phosphorylated in the presence of BDNF leading to inhibition of its actin-capping activity and stimulation of filopodia formation. Component of a complex with WHRN and MYO15A that localizes at stereocilia tips and is required for elongation of the stereocilia actin core. Indirectly involved in cell cycle progression; its degradation following ubiquitination being required during G2 phase to promote cell shape changes.
Pubmed ID | 29273203 | Journal | Journal of molecular biology |
---|---|---|---|
Title | Transcriptome-wide Identification and Validation of Interactions between the miRNA Machinery and HuR on mRNA Targets. | ||
Author | Li Y, Estep JA, Karginov FV |
Molecule | Disease | Data Source |
---|---|---|
hsa-miR-429 | acute myeloid leukemia | MNDR Database |
hsa-miR-429 | adenocarcinoma | MNDR Database |
hsa-miR-429 | Alzheimer's disease | MNDR Database |
hsa-miR-429 | autosomal recessive disease | MNDR Database |
hsa-miR-429 | azoospermia | MNDR Database |
hsa-miR-429 | Barrett's esophagus | MNDR Database |
hsa-miR-429 | biliary tract cancer | MNDR Database |
hsa-miR-429 | bladder urothelial carcinoma | MNDR Database |
hsa-miR-429 | bone disease | MNDR Database |
hsa-miR-429 | brain disease | MNDR Database |
hsa-miR-429 | breast cancer | MNDR Database |
hsa-miR-429 | Breast Neoplasms | MNDR Database |
hsa-miR-429 | cancer | MNDR Database |
hsa-miR-429 | carcinoma | MNDR Database |
hsa-miR-429 | Carcinoma, Ductal, Breast | MNDR Database |
hsa-miR-429 | Carcinoma, Non-Small-Cell Lung | MNDR Database |
hsa-miR-429 | Carcinoma, Renal Cell | MNDR Database |
hsa-miR-429 | cervical adenocarcinoma | MNDR Database |
hsa-miR-429 | cervical squamous cell carcinoma | MNDR Database |
hsa-miR-429 | cholangiocarcinoma | MNDR Database |
hsa-miR-429 | colon adenocarcinoma | MNDR Database |
hsa-miR-429 | colon cancer | MNDR Database |
hsa-miR-429 | colorectal cancer | MNDR Database |
hsa-miR-429 | Colorectal Neoplasms | MNDR Database |
hsa-miR-429 | Crohn's disease | MNDR Database |
hsa-miR-429 | diabetes mellitus | MNDR Database |
hsa-miR-429 | dilated cardiomyopathy | MNDR Database |
hsa-miR-429 | Ehrlich tumor carcinoma | MNDR Database |
hsa-miR-429 | endometrial cancer | MNDR Database |
hsa-miR-429 | endometriosis | MNDR Database |
hsa-miR-429 | esophageal cancer | MNDR Database |
hsa-miR-429 | eye disease | MNDR Database |
hsa-miR-429 | gastric adenocarcinoma | MNDR Database |
hsa-miR-429 | Gilles de la Tourette syndrome | MNDR Database |
hsa-miR-429 | Glioblastoma | MNDR Database |
hsa-miR-429 | gout | MNDR Database |
hsa-miR-429 | head and neck cancer | MNDR Database |
hsa-miR-429 | heart disease | MNDR Database |
hsa-miR-429 | Heart Failure | MNDR Database |
hsa-miR-429 | Helplessness, Learned | MNDR Database |
hsa-miR-429 | hepatocellular carcinoma | MNDR Database |
hsa-miR-429 | Her2-receptor positive breast cancer | MNDR Database |
hsa-miR-429 | Hirschsprung's disease | MNDR Database |
hsa-miR-429 | IgA glomerulonephritis | MNDR Database |
hsa-miR-429 | intellectual disability | MNDR Database |
hsa-miR-429 | intrahepatic cholangiocarcinoma | MNDR Database |
hsa-miR-429 | kidney disease | MNDR Database |
hsa-miR-429 | large cell neuroendocrine cancer | MNDR Database |
hsa-miR-429 | leukemia | MNDR Database |
hsa-miR-429 | liposarcoma | MNDR Database |
hsa-miR-429 | Liver Neoplasms | MNDR Database |
hsa-miR-429 | lung adenocarcinoma | MNDR Database |
hsa-miR-429 | lung cancer | MNDR Database |
hsa-miR-429 | lung disease | MNDR Database |
hsa-miR-429 | lung small cell carcinoma | MNDR Database |
hsa-miR-429 | lung squamous cell carcinoma | MNDR Database |
hsa-miR-429 | Machado-Joseph disease | MNDR Database |
hsa-miR-429 | malignant glioma | MNDR Database |
hsa-miR-429 | melanoma | MNDR Database |
hsa-miR-429 | mesenchymal cell neoplasm | MNDR Database |
hsa-miR-429 | Mouth Neoplasms | MNDR Database |
hsa-miR-429 | nasopharynx carcinoma | MNDR Database |
hsa-miR-429 | Neoplasms | MNDR Database |
hsa-miR-429 | nephroblastoma | MNDR Database |
hsa-miR-429 | nephrosclerosis | MNDR Database |
hsa-miR-429 | neurodegenerative disease | MNDR Database |
hsa-miR-429 | oral squamous cell carcinoma | MNDR Database |
hsa-miR-429 | osteosarcoma | MNDR Database |
hsa-miR-429 | ovarian carcinoma | MNDR Database |
hsa-miR-429 | Ovarian epithelial cancer | MNDR Database |
hsa-miR-429 | Ovarian Neoplasms | MNDR Database |
hsa-miR-429 | pancreatic cancer | MNDR Database |
hsa-miR-429 | papillary renal cell carcinoma | MNDR Database |
hsa-miR-429 | Parkinson's disease | MNDR Database |
hsa-miR-429 | pediatric osteosarcoma | MNDR Database |
hsa-miR-429 | pituitary adenoma | MNDR Database |
hsa-miR-429 | progesterone-receptor negative breast cancer | MNDR Database |
hsa-miR-429 | progesterone-receptor positive breast cancer | MNDR Database |
hsa-miR-429 | Prostatic Neoplasms | MNDR Database |
hsa-miR-429 | rectum adenocarcinoma | MNDR Database |
hsa-miR-429 | renal cell carcinoma | MNDR Database |
hsa-miR-429 | renal clear cell carcinoma | MNDR Database |
hsa-miR-429 | retinoblastoma | MNDR Database |
hsa-miR-429 | schizophrenia | MNDR Database |
hsa-miR-429 | squamous cell carcinoma | MNDR Database |
hsa-miR-429 | stomach cancer | MNDR Database |
hsa-miR-429 | systemic lupus erythematosus | MNDR Database |
hsa-miR-429 | temporal lobe epilepsy | MNDR Database |
hsa-miR-429 | testicular germ cell cancer | MNDR Database |
hsa-miR-429 | thyroid cancer | MNDR Database |
hsa-miR-429 | thyroid carcinoma | MNDR Database |
hsa-miR-429 | tonsil cancer | MNDR Database |
hsa-miR-429 | triple-receptor negative breast cancer | MNDR Database |
hsa-miR-429 | ulcerative colitis | MNDR Database |
hsa-miR-429 | urinary bladder cancer | MNDR Database |
hsa-miR-429 | Urinary Bladder Neoplasms | MNDR Database |
hsa-miR-429 | uterine corpus endometrial carcinoma | MNDR Database |
hsa-miR-429 | vascular disease | MNDR Database |
hsa-miR-429 | deafness, autosomal recessive | eDGAR Database |